Leonie Schneider is the Co-Founder of PsyPAN and a former participant in a depression clinical trial.
CV of Leonie Schneider
In November 2019, Leonie was a participant in the second Psilocybin for Depression clinical trial (PsiloDep 2) at Imperial College. It provided a turning point in how Leonie relates to her depression and provided a new path to deep personal healing and focused professional action.
Leonie has since redirected her efforts to expand access to psychedelic-assisted therapies by actively advocating for the safe and intentional use of psychedelics.
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)